Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation

Ginkgo Bioworks (NYSE: DNA) will present its fourth quarter and full year 2025 results on Thursday, February 26, 2026 at 4:30 p.m. ET.

Rhea-AI Summary

Ginkgo Bioworks (NYSE: DNA) will present its fourth quarter and full year 2025 results on Thursday, February 26, 2026 at 4:30 p.m. ET. The company said the presentation will include a review of business performance for the period ended December 31, 2025, with a live webcast and later replay available on its investor relations website.

Investors can submit questions in advance via X (hashtag #GinkgoResults) or by emailing investors@ginkgobioworks.com.

Argus Feb 19 session

+8.27% close to close Open Argus

Details

News Market Reaction – DNA

On Feb 19, the day this news came out, DNA closed 8.27% above the previous close.

Data tracked by StockTitan Argus for the Feb 19 session.

Market Context

On Feb 19, the day this news came out, the stock closed 8.3% above the previous close. A strong posi...

Analysis

On Feb 19, the day this news came out, the stock closed 8.3% above the previous close. A strong positive reaction aligns with expectations that earnings dates can concentrate attention on upcoming fundamentals. Past news, such as the ARPA-H oncology partnership with a 8.52% move, showed the stock responding to clear catalysts. However, existing capital-raising capacity under the Form S-3 and prior at-the-market authorization could remain an overhang if used more extensively, so investors historically watched subsequent filings closely.

Key Figures

Earnings period end: December 31, 2025 Results presentation date: February 26, 2026 Presentation time: 4:30 p.m. ET

Earnings period end

December 31, 2025

Fourth quarter and full year 2025 results period

Results presentation date

February 26, 2026

Scheduled post-market earnings presentation

Presentation time

4:30 p.m. ET

Start time for Q4 and full-year 2025 review

Historical Context

5 past events · Latest: Feb 05

5 events

1. Feb 05

   AI lab benchmark

   24h Move

   +0.6%

   AI-driven autonomous lab cut protein synthesis costs versus prior benchmarks.

2. Jan 13

   Conference appearance

   24h Move

   +0.6%

   Planned presentation at the J.P. Morgan Healthcare Conference for investor outreach.

3. Dec 22

   Oncology partnership

   24h Move

   +8.5%

   ARPA-H–backed collaboration on innovative pill-based cancer screening tools.

4. Dec 17

   Agriculture collaboration

   24h Move

   -0.2%

   Collaboration with Agricen to optimize fermentation for soil amendment product.

5. Dec 09

   Drug safety project

   24h Move

   +1.7%

   Deep Origin-led ARPA-H project using Ginkgo’s platform for drug safety data.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Presentation and Q&A session scheduled for post-market on Thursday, February 26, 2026

BOSTON, Feb. 19, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced that it plans to host a presentation and Q&A session reviewing business performance for the fourth quarter and full year ended December 31, 2025, on Thursday, February 26, 2026, beginning at 4:30 p.m. ET.

The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks
Ginkgo Bioworks builds the tools that make biology easier to engineer for everyone. The company offers autonomous laboratories that replace manual laboratory work with robotics in the lab, greatly improving the productivity of scientists. Ginkgo's in-house autonomous lab is also available as a "cloud lab" through our Datapoints and Solutions contract research services. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com

MEDIA CONTACT:

press@ginkgobioworks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-fourth-quarter-and-full-year-2025-results-presentation-302691775.html

SOURCE Ginkgo Bioworks

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Ginkgo Bioworks (DNA) present its Q4 and full year 2025 results?

Ginkgo will present on Thursday, February 26, 2026 at 4:30 p.m. ET, with a post-market presentation and Q&A. According to Ginkgo, the presentation reviews results for the period ended December 31, 2025 and will be webcast with a replay available.

How can investors watch the Ginkgo Bioworks (DNA) February 26, 2026 webcast?

Investors can view the live webcast via Ginkgo's investor relations website and access a replay afterward. According to Ginkgo, the presentation details and webcast link will be posted at investors.ginkgobioworks.com.

How can I submit questions ahead of the Ginkgo Bioworks (DNA) results presentation?

Submit questions in advance via X using #GinkgoResults or email investors@ginkgobioworks.com. According to Ginkgo, both channels are provided to collect investor questions before the February 26, 2026 post-market presentation.

What period will Ginkgo Bioworks (DNA) review during the February 26, 2026 presentation?

The presentation will review business performance for the fourth quarter and full year ended December 31, 2025. According to Ginkgo, the session includes a Q&A to discuss that quarter and full-year performance in detail.

Will there be a replay of the Ginkgo Bioworks (DNA) February 26, 2026 presentation?

Yes. Ginkgo said a replay of the webcast will be made available after the live presentation. According to Ginkgo, the replay will be accessible on the company's investor relations website for later viewing.

What time zone is used for the Ginkgo Bioworks (DNA) February 26, 2026 presentation start time?

The presentation begins at 4:30 p.m. ET on February 26, 2026, as stated by Ginkgo. According to Ginkgo, this is a post-market event scheduled in Eastern Time with a live webcast and replay options.